• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I型黏多糖贮积症(Hurler综合征)的临床表现。

The presenting features of mucopolysaccharidosis type IH (Hurler syndrome).

作者信息

Cleary M A, Wraith J E

机构信息

Willink Biochemical Genetics Unit, Royal Manchester Children's Hospital, UK.

出版信息

Acta Paediatr. 1995 Mar;84(3):337-9. doi: 10.1111/j.1651-2227.1995.tb13640.x.

DOI:10.1111/j.1651-2227.1995.tb13640.x
PMID:7780260
Abstract

The presenting features of 39 patients with mucopolysaccharidosis (MPS) type IH are described. The mean age at diagnosis was approximately 9 months and it is difficult to see how this can be reduced without consideration of newborn screening. An earlier age at diagnosis is likely to lead to better results following therapy such as bone marrow transplantation. Clinical features which should arouse suspicion of MPS IH include frequent ENT surgery and recurrent herniae. Clinical vigilance is needed for early diagnosis.

摘要

本文描述了39例I型黏多糖贮积症(MPS)患者的临床表现。诊断时的平均年龄约为9个月,若不考虑新生儿筛查,很难看出如何能降低这一年龄。诊断时年龄较小可能会使骨髓移植等治疗后取得更好的效果。应引起对I型MPS怀疑的临床特征包括频繁的耳鼻喉科手术和复发性疝。早期诊断需要临床警惕。

相似文献

1
The presenting features of mucopolysaccharidosis type IH (Hurler syndrome).I型黏多糖贮积症(Hurler综合征)的临床表现。
Acta Paediatr. 1995 Mar;84(3):337-9. doi: 10.1111/j.1651-2227.1995.tb13640.x.
2
Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.黏多糖贮积症 I 型患者的成纤维细胞中残留的α-L-艾杜糖苷酸酶活性。
Mol Genet Metab. 2013 Aug;109(4):377-81. doi: 10.1016/j.ymgme.2013.05.016. Epub 2013 Jun 4.
3
Hematopoietic cell transplantation for severe MPS I in the first six months of life: The heart of the matter.六个月龄内接受造血细胞移植治疗重型黏多糖贮积症 I 型:关键所在。
Mol Genet Metab. 2019 Feb;126(2):117-120. doi: 10.1016/j.ymgme.2018.11.007. Epub 2018 Nov 13.
4
Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings.早期酶替代疗法可使Ⅰ型黏多糖贮积症成功进行造血干细胞移植:两名日本兄妹的不同临床结局
Brain Dev. 2019 Jun;41(6):546-550. doi: 10.1016/j.braindev.2019.01.008. Epub 2019 Feb 10.
5
Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).6例I型黏多糖贮积症(胡勒综合征)患儿造血干细胞移植后的结局
Acta Paediatr. 2008 Aug;97(8):1108-12. doi: 10.1111/j.1651-2227.2008.00811.x. Epub 2008 Apr 29.
6
Failure to shorten the diagnostic delay in two ultra-orphan diseases (mucopolysaccharidosis types I and III): potential causes and implications.未能缩短两种超罕见疾病(黏多糖贮积症 I 型和 III 型)的诊断延迟:潜在原因和影响。
Orphanet J Rare Dis. 2018 Jan 8;13(1):2. doi: 10.1186/s13023-017-0733-y.
7
Mucopolysaccharidosis type I.I型黏多糖贮积症
Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:102-6.
8
Hematopoietic cell transplantation for Mucopolysaccharidosis I in the presence of decreased cardiac function.心功能降低情况下黏多糖贮积症I型的造血细胞移植
Mol Genet Metab. 2023 Nov;140(3):107669. doi: 10.1016/j.ymgme.2023.107669. Epub 2023 Jul 27.
9
Easy-to-use algorithm would provide faster diagnoses for mucopolysaccharidosis type I and enable patients to receive earlier treatment.易于使用的算法将为黏多糖贮积症 I 型提供更快的诊断,并使患者能够更早接受治疗。
Acta Paediatr. 2018 Aug;107(8):1402-1408. doi: 10.1111/apa.14417.
10
Elevated cerebral spinal fluid biomarkers in children with mucopolysaccharidosis I-H.黏多糖贮积症 I-H 患儿脑脊液生物标志物升高。
Sci Rep. 2016 Dec 2;6:38305. doi: 10.1038/srep38305.

引用本文的文献

1
Antibodies to recombinant human alpha-L-iduronidase prevent disease correction in cortical bone in MPS I mice.抗重组人α-L-艾杜糖醛酸酶抗体可阻止MPS I型小鼠皮质骨疾病的纠正。
Mol Ther Methods Clin Dev. 2025 Jan 2;33(1):101405. doi: 10.1016/j.omtm.2024.101405. eCollection 2025 Mar 13.
2
Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS I.鞘内或静脉注射最小有效剂量的腺相关病毒9型-艾杜糖醛酸酶/ RGX - 111可预防小鼠黏多糖贮积症I型的心脏、骨骼和神经表现。
Mol Ther Methods Clin Dev. 2024 Nov 4;32(4):101369. doi: 10.1016/j.omtm.2024.101369. eCollection 2024 Dec 12.
3
Juvenile sialidosis: a rare case and review of the literature.
青少年涎酸沉积症:1例罕见病例及文献复习
Ann Med Surg (Lond). 2024 Feb 28;86(4):2248-2252. doi: 10.1097/MS9.0000000000001768. eCollection 2024 Apr.
4
MPSI Manifestations and Treatment Outcome: Skeletal Focus.MPSI 表现与治疗结局:骨骼病灶。
Int J Mol Sci. 2022 Sep 22;23(19):11168. doi: 10.3390/ijms231911168.
5
Adjunct diagnostic value of radiological findings in mucopolysaccharidosis type IVa-related thoracic spinal abnormalities: a pilot study.影像学表现对 IVA 型黏多糖贮积症相关胸段脊柱异常的辅助诊断价值:一项初步研究。
Orphanet J Rare Dis. 2022 Jul 29;17(1):296. doi: 10.1186/s13023-022-02449-9.
6
Induced Pluripotent Stem Cells to Understand Mucopolysaccharidosis. I: Demonstration of a Migration Defect in Neural Precursors.诱导多能干细胞理解黏多糖贮积症。I:神经前体细胞迁移缺陷的证明。
Cells. 2020 Dec 3;9(12):2593. doi: 10.3390/cells9122593.
7
Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type I.黏多糖贮积症 I 型患者的治疗时间得到改善,但诊断时间没有变化。
Arch Dis Child. 2021 Jul;106(7):674-679. doi: 10.1136/archdischild-2020-319040. Epub 2020 Nov 2.
8
Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.黏多糖贮积症 I 型:自然病史和分子病理学综述。
Cells. 2020 Aug 5;9(8):1838. doi: 10.3390/cells9081838.
9
Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism.先天性代谢缺陷中的造血干细胞移植
Front Pediatr. 2019 Oct 25;7:433. doi: 10.3389/fped.2019.00433. eCollection 2019.
10
"Missing mutations" in MPS I: Identification of two novel copy number variations by an IDUA-specific in house MLPA assay.黏多糖贮积症 I 型中的“缺失突变”:通过 IDUA 特异性的内建 MLPA 分析鉴定两种新的拷贝数变异。
Mol Genet Genomic Med. 2019 Sep;7(9):e00615. doi: 10.1002/mgg3.615. Epub 2019 Jul 18.